LABU - Biotech Recovery Rally!

Biotech had a deep bear market and finally became very oversold in October. Market conditions have been generally improving and Biotech is a sector that may benefit more than most due to the oversold condition. Since October LABU has doubled and appears to be still early in a recovery rally from oversold conditions. Daily charts